Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Jaw Muscle Myalgia
NCT04426123Phase 2Unknown
- Sponsor
- Region Örebro län
- Start
- Jul 2020
- Primary completion
- Dec 2020
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of botulinum toxin type A in Masticatory muscle myalgia (MMM), myofascial pain syndrome (MPS), sponsored by Region Örebro län. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
Masticatory muscle myalgia (MMM)myofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT04426123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04426123.